Hans Wigzell

Insider Reports History

Location
Hagersten, Sweden
Signature
/s/ Cristin Rothfuss, as Attorney-in-Fact for Hans Wigzell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans Wigzell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Director Common Stock 25.2K $2.53M $100.13 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Options (right to buy) 4.79K 10 Mar 2025 Direct
Sarepta Therapeutics, Inc. Director Stock Option (right to buy) 0 08 Mar 2024 Direct

Insider Reports Filed by Hans Wigzell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRPT Sarepta Therapeutics, Inc. 10 Mar 2025 2 $0 4 11 Mar 2025 Director
SRPT Sarepta Therapeutics, Inc. 12 Dec 2024 3 -$1.17M 4 16 Dec 2024 Director
SRPT Sarepta Therapeutics, Inc. 08 Mar 2024 5 -$1.64M 4 11 Mar 2024 Director
SRPT Sarepta Therapeutics, Inc. 01 Mar 2024 2 $0 4 05 Mar 2024 Director
SRPT Sarepta Therapeutics, Inc. 04 Aug 2023 3 -$1.17M 4 08 Aug 2023 Director
SRPT Sarepta Therapeutics, Inc. 06 Mar 2023 2 $0 4 08 Mar 2023 Director
SRPT Sarepta Therapeutics, Inc. 07 Mar 2022 2 $0 4 08 Mar 2022 Director